The induction and function of the anti-inflammatory fate of T
Animals
Cell Plasticity
/ immunology
Disease Resistance
/ genetics
HEK293 Cells
Homeostasis
/ immunology
Humans
Inflammation
/ immunology
Interleukin-10
/ genetics
Interleukin-17
/ genetics
Intestines
/ immunology
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Staphylococcal Infections
/ immunology
Staphylococcus aureus
/ immunology
Th17 Cells
/ immunology
Transforming Growth Factor beta
/ immunology
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
03 07 2020
03 07 2020
Historique:
received:
03
10
2019
accepted:
11
06
2020
entrez:
5
7
2020
pubmed:
6
7
2020
medline:
1
9
2020
Statut:
epublish
Résumé
T
Identifiants
pubmed: 32620760
doi: 10.1038/s41467-020-17097-5
pii: 10.1038/s41467-020-17097-5
pmc: PMC7335205
doi:
Substances chimiques
Interleukin-17
0
Transforming Growth Factor beta
0
Interleukin-10
130068-27-8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3334Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Références
Curtis, M. M. & Way, S. S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126, 177–185 (2009).
pubmed: 19125888
pmcid: 2632692
Zhang, S. et al. Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature 551, 105–109 (2017).
pubmed: 29072299
pmcid: 5743442
Puel, A. et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332, 65–68 (2011).
pubmed: 21350122
pmcid: 3070042
Holland, S. M. et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med 357, 1608–1619 (2007).
pubmed: 17881745
Zhang, Q. et al. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 361, 2046–2055 (2009).
pubmed: 19776401
pmcid: 2965730
Esplugues, E. et al. Control of TH17 cells occurs in the small intestine. Nature 475, 514–518 (2011).
pubmed: 21765430
pmcid: 3148838
Gagliani, N. et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221–225 (2015).
pubmed: 25924064
pmcid: 4498984
Omenetti, S. et al. The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 Cells. Immunity 51, 77–89 e76 (2019).
pubmed: 31229354
pmcid: 6642154
Mangan, P. R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231–234 (2006).
pubmed: 16648837
Zhou, L. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967–974 (2007).
pubmed: 17581537
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942–949 (2007).
pubmed: 17676045
Wilson, N. J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950–957 (2007).
pubmed: 17676044
Xu, J. et al. c-Maf regulates IL-10 expression during Th17 polarization. J. Immunol. 182, 6226–6236 (2009).
pubmed: 19414776
pmcid: 2834209
Chang, K. K. et al. IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORgammat/Blimp-1 signal to promote the progression of endometriosis. Cell Death Dis. 8, e2666 (2017).
pubmed: 28300844
pmcid: 5386585
Gabrysova, L. et al. c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4(+) T cells. Nat. Immunol. 19, 497–507 (2018).
pubmed: 29662170
pmcid: 5988041
Aschenbrenner, D. et al. An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells. Nat. Immunol. 19, 1126–1136 (2018).
pubmed: 30201991
pmcid: 6402560
McGeachy, M. J. et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390–1397 (2007).
pubmed: 17994024
Martinez, G. J. et al. Smad2 positively regulates the generation of Th17 cells. The. J. Biol. Chem. 285, 29039–29043 (2010).
pubmed: 20667820
pmcid: 2937933
Martinez, G. J. et al. Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J. Biol. Chem. 284, 35283–35286 (2009).
pubmed: 19887374
pmcid: 2790957
Xi, Q. et al. A poised chromatin platform for TGF-beta access to master regulators. Cell 147, 1511–1524 (2011).
pubmed: 22196728
pmcid: 3582033
He, W. et al. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125, 929–941 (2006).
pubmed: 16751102
Tanaka, S. et al. Trim33 mediates the proinflammatory function of Th17 cells. J. Exp. Med 215, 1853–1868 (2018).
pubmed: 29930104
pmcid: 6028517
Uhlig, H. H. et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 177, 5852–5860 (2006).
pubmed: 17056509
pmcid: 6108413
Round, J. L. & Mazmanian, S. K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204–12209 (2010).
pubmed: 20566854
Huber, S. et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(−) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34, 554–565 (2011).
pubmed: 21511184
pmcid: 3113617
Zielinski, C. E. et al. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484, 514–518 (2012).
pubmed: 22466287
Chatenoud, L. & Bluestone, J. A. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol. 7, 622–632 (2007).
pubmed: 17641665
Rutz, S. et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 518, 417–421 (2015).
pubmed: 25470037
Karmaus, P. W. F. et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature 565, 101–105 (2019).
pubmed: 30568299
Weaver, C. T., Elson, C. O., Fouser, L. A. & Kolls, J. K. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 8, 477–512 (2013).
pubmed: 23157335
Turner, J. E., Paust, H. J., Steinmetz, O. M. & Panzer, U. The Th17 immune response in renal inflammation. Kidney Int. 77, 1070–1075 (2010).
pubmed: 20375986
Tesmer, L. A., Lundy, S. K., Sarkar, S. & Fox, D. A. Th17 cells in human disease. Immunol. Rev. 223, 87–113 (2008).
pubmed: 18613831
pmcid: 3299089
Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M. & Gagliani, N. The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases. Immunity 49, 1004–1019 (2018).
pubmed: 30566879
Yang, B. H. et al. Foxp3(+) T cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 9, 444–457 (2016).
pubmed: 26307665
Sefik, E. et al. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 349, 993–997 (2015).
pubmed: 26272906
pmcid: 4700932
Lochner, M. et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 205, 1381–1393 (2008).
pubmed: 18504307
pmcid: 2413035
Ghoreschi, K. et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467, 967–971 (2010).
pubmed: 20962846
pmcid: 3108066
Delisle, J. S. et al. The TGF-beta-Smad3 pathway inhibits CD28-dependent cell growth and proliferation of CD4 T cells. Genes Immun. 14, 115–126 (2013).
pubmed: 23328844
Neumann, C. et al. Role of Blimp-1 in programing Th effector cells into IL-10 producers. J. Exp. Med 211, 1807–1819 (2014).
pubmed: 25073792
pmcid: 4144744
Huss, D. J. et al. TGF-beta signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. Eur. J. Immunol. 41, 2987–2996 (2011).
pubmed: 21728174
pmcid: 3478765
Huss, D. J. et al. TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10. J. Immunol. 184, 5628–5636 (2010).
pubmed: 20393141
pmcid: 3804066
Salehi, S. et al. B lymphocyte-induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17-producing CD4+ T cells. J. Immunol. 189, 5682–5693 (2012).
pubmed: 23162130
pmcid: 3529138
Chu, G. C., Dunn, N. R., Anderson, D. C., Oxburgh, L. & Robertson, E. J. Differential requirements for Smad4 in TGFbeta-dependent patterning of the early mouse embryo. Development 131, 3501–3512 (2004).
pubmed: 15215210
Kim, J. & Kaartinen, V. Generation of mice with a conditional allele for Trim33. Genesis 46, 329–333 (2008).
pubmed: 18543301
pmcid: 2504017
Lefrancois, L. & Lycke, N. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer’s patch, and lamina propria cells. Curr. Protoc. Immunol. https://doi.org/10.1002/0471142735.im0319s17 (2001).
Perez, L. G. et al. TGF-beta signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer. Nat. Commun. 11, 2608 (2020).
pubmed: 32451418
pmcid: 7248087